A viable vaccine for tough tumors

Grantee News
November 12, 2020

While immunotherapies work well for some cancers, others are immune-resistant and condemn patients to the severe side effects of long-term chemo treatment. A new cancer vaccine successfully treated immune-resistant breast cancer in mice, 100% of which survived a second injection of cancer cells, indicating long-term immunity with no side effects. Read more from the Wyss Institute.

Health Tags
Breast Cancer
Research Tags
Immunoengineering